about
Bloodstream infections by Malassezia and Candida species in critical care patients.Unlicensed and off-label use of medicines at a neonatology clinic in Italy.Bovine lactoferrin supplementation for prevention of late-onset sepsis in very low-birth-weight neonates: a randomized trial.COQ4 mutations cause a broad spectrum of mitochondrial disorders associated with CoQ10 deficiency.Correlation between lactoferrin and beneficial microbiota in breast milk and infant's feces.Diagnostic performance of 1→3-β-d-glucan in neonatal and pediatric patients with Candidemia.Hyperphosphatemic familial tumoral calcinosis: odontostomatologic management and pathological features.Molecular and Functional Characterization of Three Different Postzygotic Mutations in PIK3CA-Related Overgrowth Spectrum (PROS) Patients: Effects on PI3K/AKT/mTOR Signaling and Sensitivity to PIK3 Inhibitors.Administration of a multistrain probiotic product (VSL#3) to women in the perinatal period differentially affects breast milk beneficial microbiota in relation to mode of delivery.The role of molecular genetics in the pathogenesis and diagnosis of neonatal sepsis.The role of procalcitonin in neonatal intensive care unit patients with candidemia.Lactoferrin and prevention of late-onset sepsis in the pre-term neonates.Prematurity and low weight at birth as new conditions predisposing to an increased cardiovascular risk.Candidemia in the Neonatal Intensive Care Unit: A Retrospective, Observational Survey and Analysis of Literature Data.Severe hypoglycemia during successful treatment of diffuse hemangiomatosis with propranolol.Bovine lactoferrin supplementation for prevention of necrotizing enterocolitis in very-low-birth-weight neonates: a randomized clinical trial.Renal vein thrombosis in a newborn with prothrombotic genetic risk factors.Gastric electrical activity and gastric emptying in preterm newborns fed standard and hydrolysate formulas.Helicobacter pylori detection by stool antigen test in the perinatal period: an inadequate approach to establish maternal transmission.Bovine lactoferrin prevents invasive fungal infections in very low birth weight infants: a randomized controlled trial.Allergic colitis in monozygotic preterm twins.Mild ventriculomegaly as a counselling challenge.Human milk feeding prevents retinopathy of prematurity (ROP) in preterm VLBW neonates.De novo unbalanced translocation leading to monosomy 9p24.3p24.1 and trisomy 19q13.42q13.43 characterized by microarray-based comparative genomic hybridization in a child with partial cortical dysplasia and craniofacial dysmorphisms without trigonoceFecal calprotectin (FC) in newborns: is it a predictive marker of gastrointestinal and/or allergic disease?Longitudinally evaluation of human-beta defensins and Tumor necrosis factor- alfa in stools of preterm and term newbornsDuration of meconium passage in preterm and term infantsLactobacillus GG Improves Recovery in Infants with Blood in the Stools and Presumptive Allergic Colitis Compared with Extensively Hydrolyzed Formula AloneThe source of Helicobacter pylori infection in the neonatal periodA Rare Case of Severe Congenital RYR1-Associated MyopathyNeonatal hyperbilirubinemia and Gilbert's syndromeThe Role of Oxidative Stress in the Pathomechanism of Congenital MalformationsA case of fetal midgut volvulus and jejunal atresia: nutritional support and maintenance of mucosal function and integrityCardiac function in congenital hypothyroidism: impairment and response to L-T4 therapyThyroid function after prolonged treatment for congenital hypothyroidismEvaluation of the growth-hormone-releasing hormone test in short normal and growth-hormone-deficient childrenMaternal and neonatal lead exposure in southern ItalyEffect of hyperbilirubinemia on intestinal permeability in healthy term newbornsCytokine gene polymorphisms in Italian preterm infants: association between interleukin-10 -1082 G/A polymorphism and respiratory distress syndromeEarly low-dose hydrocortisone in very preterm infants: a randomized, placebo-controlled trial
P50
Q31151975-8DBBD34B-7D4B-4182-96F7-348DBCEFD1D7Q34577410-3023F9E8-FE6C-46A0-BB11-A0B0A5351A25Q34659239-291664CE-D20A-4992-B9BA-FF0ADA21874EQ35059346-01D675A6-13E0-41ED-80E1-311E24EB9642Q35196087-E7D75ABD-F44C-4CF8-905C-E82F2B38592CQ35297182-415259AD-5E19-4667-8341-07A06BA02842Q35533372-C2395AAF-558B-4CE2-830B-83C20DBBEFBAQ35542297-6BFE3780-3A47-414D-9BE6-D9ECE54ACB31Q35594223-00863B4A-9662-487D-90E8-70CAC6466C97Q35796345-6DF75989-4C24-4CBF-B38B-7B343ED0122BQ36465021-92822033-708A-459C-8D64-BEFE38888190Q37688611-97850941-430C-4B73-B8D0-3384E6225A2DQ37985798-077EBC01-B705-4788-A232-8D6D78F94CF7Q40051828-92FE2B94-B5E8-4DAD-8E03-66B62EE76832Q43034223-B58CCCD2-C788-4B3A-A6A6-DC104500311EQ43495143-0D792E7C-18D6-4852-A448-85D17B2244C2Q43602097-CBF95F2C-44DB-4BFD-8E8D-36F504EC17B9Q43761241-2225EE5E-8269-4846-82D1-830BDA4A11BDQ44750064-01943239-8ABB-4E46-ABBB-89F787AC69ABQ45168991-FC822843-F6AD-4DBB-BCB7-EAA38AB21EB0Q45752317-AFC4779F-AC59-4AC1-9FFC-973F120BD650Q48721039-53AC37A3-B938-4943-AE68-54B9E74DC7D0Q50798321-BCCC0354-1FF6-404A-A7EE-CD8D64A6B267Q56320335-9FC505DA-F5B5-4EF0-A168-C76586876F1BQ57999044-E199270A-93FD-4CF1-8648-DD1DFADA0870Q57999046-5B00D49E-E8BA-4253-B337-9EA4DF632609Q57999050-66716F45-5A83-4BBB-8288-E494DF65015CQ57999054-23927DD6-F2BA-47D8-AD68-9E6B28898B19Q57999060-AE5D8A71-A21D-43AC-89FE-28F21B304E99Q58805854-3CDE126F-98D0-4739-9DD0-0A596FF572EDQ59672641-A798E977-736B-4B0F-8114-2018DA948A5BQ61453869-76D4DBB1-6261-434F-A216-E2902FA62829Q64044551-95E00F8D-9FE2-42BA-8058-0DEAFB83B616Q68203503-5D844C30-D3C3-4ECE-AFC9-C005DDE8579CQ68613210-81212B55-0E65-4162-99E2-F5FB132369A0Q70237886-888F3C9F-06FD-4EC1-9580-7F2A3B3C06BEQ74624676-C0EF17B9-B898-4BF5-A3FA-7A028E0F00E1Q79450003-87753FA1-ABC5-4688-942F-8179E67038BEQ79809826-37C3B193-7A38-4F18-9F47-9CAD82145A6BQ80475751-5DDB0E66-22FC-44F5-82C2-D258AC9CFAD0
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Nicola Laforgia
@ast
Nicola Laforgia
@en
Nicola Laforgia
@es
Nicola Laforgia
@nl
type
label
Nicola Laforgia
@ast
Nicola Laforgia
@en
Nicola Laforgia
@es
Nicola Laforgia
@nl
prefLabel
Nicola Laforgia
@ast
Nicola Laforgia
@en
Nicola Laforgia
@es
Nicola Laforgia
@nl
P106
P1153
55938043300
P21
P31
P496
0000-0002-4610-1216